Selected research
Industry Growth & Trends
Global Comprehensive Genomic Profiling Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Comprehensive Genomic Profiling market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Comprehensive Genomic Profiling is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Comprehensive Genomic Profiling is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Comprehensive Genomic Profiling is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Comprehensive Genomic Profiling market include Tempus AI, Labcorp, NeoGenomics, Exact Sciences, Personalis, Illumina, Thermo Fisher Scientific, QIAGEN and Agilent Technologies, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Comprehensive Genomic Profiling market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Comprehensive Genomic Profiling market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Comprehensive Genomic Profiling market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Comprehensive Genomic Profiling.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Comprehensive Genomic Profiling market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Comprehensive Genomic Profiling Market by Company
Tempus AI
Labcorp
NeoGenomics
Exact Sciences
Personalis
Illumina
Thermo Fisher Scientific
QIAGEN
Agilent Technologies
SOPHiA GENETICS
Sysmex
Burning Rock Biotech
Genetron Health
Geneseeq
BGI Genomics
Amoy Diagnostics
Roche
Guardant Health
Caris Life Sciences
Comprehensive Genomic Profiling Segment by Type
Tissue-based Profiling
Liquid Biopsy Profiling
Other
Comprehensive Genomic Profiling Segment by Application
Hospitals and Cancer Centers
Independent Clinical Laboratories
Pharmaceutical and Biotechnology Companies
Other
Comprehensive Genomic Profiling Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Comprehensive Genomic Profiling market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Comprehensive Genomic Profiling and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Comprehensive Genomic Profiling.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Comprehensive Genomic Profiling companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Tissue-based Profiling
- Liquid Biopsy Profiling
- Other
Applications
- Hospitals and Cancer Centers
- Independent Clinical Laboratories
- Pharmaceutical and Biotechnology Companies
- Other
Companies covered
- Tempus AI
- Labcorp
- NeoGenomics
- Exact Sciences
- Personalis
- Illumina
- Thermo Fisher Scientific
- QIAGEN
- Agilent Technologies
- SOPHiA GENETICS
- Sysmex
- Burning Rock Biotech
- Genetron Health
- Geneseeq
- BGI Genomics
- Amoy Diagnostics
- Roche
- Guardant Health
- Caris Life Sciences
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Comprehensive Genomic Profiling Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Comprehensive Genomic Profiling Market Size by Region (2021-2032)
- 1.4.1 Global Comprehensive Genomic Profiling Market Size by Region (2021-2026)
- 1.4.2 Global Comprehensive Genomic Profiling Market Size by Region (2027-2032)
- 1.5 Key Regions Comprehensive Genomic Profiling Market Size (2021-2032)
- 1.5.1 North America Comprehensive Genomic Profiling Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Comprehensive Genomic Profiling Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Comprehensive Genomic Profiling Market Size Growth Rate (2021-2032)
- 1.5.4 South America Comprehensive Genomic Profiling Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Comprehensive Genomic Profiling Market Size Growth Rate (2021-2032)
2 Comprehensive Genomic Profiling Market by Type
- 2.1 Type Introduction
- 2.1.1 Tissue-based Profiling
- 2.1.2 Liquid Biopsy Profiling
- 2.1.3 Other
- 2.2 Global Comprehensive Genomic Profiling Market Size by Type
- 2.2.1 Global Comprehensive Genomic Profiling Market Size Overview by Type (2021-2032)
- 2.2.2 Global Comprehensive Genomic Profiling Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Comprehensive Genomic Profiling Market Size Forecasted by Type (2027-2032)
- 2.3 Global Comprehensive Genomic Profiling Market Size by Regions
- 2.3.1 North America Comprehensive Genomic Profiling Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Comprehensive Genomic Profiling Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Comprehensive Genomic Profiling Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Comprehensive Genomic Profiling Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Comprehensive Genomic Profiling Market Size Breakdown by Type (2021-2026)
3 Comprehensive Genomic Profiling Market by Application
- 3.1 Type Introduction
- 3.1.1 Hospitals and Cancer Centers
- 3.1.2 Independent Clinical Laboratories
- 3.1.3 Pharmaceutical and Biotechnology Companies
- 3.1.4 Other
- 3.2 Global Comprehensive Genomic Profiling Market Size by Application
- 3.2.1 Global Comprehensive Genomic Profiling Market Size Overview by Application (2021-2032)
- 3.2.2 Global Comprehensive Genomic Profiling Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Comprehensive Genomic Profiling Market Size Forecasted by Application (2027-2032)
- 3.3 Global Comprehensive Genomic Profiling Market Size by Regions
- 3.3.1 North America Comprehensive Genomic Profiling Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Comprehensive Genomic Profiling Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Comprehensive Genomic Profiling Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Comprehensive Genomic Profiling Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Comprehensive Genomic Profiling Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Comprehensive Genomic Profiling Industry Trends
- 4.2 Comprehensive Genomic Profiling Industry Drivers
- 4.3 Comprehensive Genomic Profiling Industry Opportunities and Challenges
- 4.4 Comprehensive Genomic Profiling Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Comprehensive Genomic Profiling Revenue (2021-2026)
- 5.2 Global Comprehensive Genomic Profiling Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Comprehensive Genomic Profiling Key Company Headquarters & Area Served
- 5.4 Global Comprehensive Genomic Profiling Company, Product Type & Application
- 5.5 Global Comprehensive Genomic Profiling Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Comprehensive Genomic Profiling Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Comprehensive Genomic Profiling Players Market Share by Revenue in 2025
- 5.6.3 2025 Comprehensive Genomic Profiling Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Tempus AI
- 6.1.1 Tempus AI Company Information
- 6.1.2 Tempus AI Business Overview
- 6.1.3 Tempus AI Comprehensive Genomic Profiling Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Tempus AI Comprehensive Genomic Profiling Product Portfolio
- 6.1.5 Tempus AI Recent Developments
- 6.2 Labcorp
- 6.2.1 Labcorp Company Information
- 6.2.2 Labcorp Business Overview
- 6.2.3 Labcorp Comprehensive Genomic Profiling Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Labcorp Comprehensive Genomic Profiling Product Portfolio
- 6.2.5 Labcorp Recent Developments
- 6.3 NeoGenomics
- 6.3.1 NeoGenomics Company Information
- 6.3.2 NeoGenomics Business Overview
- 6.3.3 NeoGenomics Comprehensive Genomic Profiling Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 NeoGenomics Comprehensive Genomic Profiling Product Portfolio
- 6.3.5 NeoGenomics Recent Developments
- 6.4 Exact Sciences
- 6.4.1 Exact Sciences Company Information
- 6.4.2 Exact Sciences Business Overview
- 6.4.3 Exact Sciences Comprehensive Genomic Profiling Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Exact Sciences Comprehensive Genomic Profiling Product Portfolio
- 6.4.5 Exact Sciences Recent Developments
- 6.5 Personalis
- 6.5.1 Personalis Company Information
- 6.5.2 Personalis Business Overview
- 6.5.3 Personalis Comprehensive Genomic Profiling Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Personalis Comprehensive Genomic Profiling Product Portfolio
- 6.5.5 Personalis Recent Developments
- 6.6 Illumina
- 6.6.1 Illumina Company Information
- 6.6.2 Illumina Business Overview
- 6.6.3 Illumina Comprehensive Genomic Profiling Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Illumina Comprehensive Genomic Profiling Product Portfolio
- 6.6.5 Illumina Recent Developments
- 6.7 Thermo Fisher Scientific
- 6.7.1 Thermo Fisher Scientific Company Information
- 6.7.2 Thermo Fisher Scientific Business Overview
- 6.7.3 Thermo Fisher Scientific Comprehensive Genomic Profiling Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Thermo Fisher Scientific Comprehensive Genomic Profiling Product Portfolio
- 6.7.5 Thermo Fisher Scientific Recent Developments
- 6.8 QIAGEN
- 6.8.1 QIAGEN Company Information
- 6.8.2 QIAGEN Business Overview
- 6.8.3 QIAGEN Comprehensive Genomic Profiling Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 QIAGEN Comprehensive Genomic Profiling Product Portfolio
- 6.8.5 QIAGEN Recent Developments
- 6.9 Agilent Technologies
- 6.9.1 Agilent Technologies Company Information
- 6.9.2 Agilent Technologies Business Overview
- 6.9.3 Agilent Technologies Comprehensive Genomic Profiling Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Agilent Technologies Comprehensive Genomic Profiling Product Portfolio
- 6.9.5 Agilent Technologies Recent Developments
- 6.10 SOPHiA GENETICS
- 6.10.1 SOPHiA GENETICS Company Information
- 6.10.2 SOPHiA GENETICS Business Overview
- 6.10.3 SOPHiA GENETICS Comprehensive Genomic Profiling Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 SOPHiA GENETICS Comprehensive Genomic Profiling Product Portfolio
- 6.10.5 SOPHiA GENETICS Recent Developments
- 6.11 Sysmex
- 6.11.1 Sysmex Company Information
- 6.11.2 Sysmex Business Overview
- 6.11.3 Sysmex Comprehensive Genomic Profiling Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Sysmex Comprehensive Genomic Profiling Product Portfolio
- 6.11.5 Sysmex Recent Developments
- 6.12 Burning Rock Biotech
- 6.12.1 Burning Rock Biotech Company Information
- 6.12.2 Burning Rock Biotech Business Overview
- 6.12.3 Burning Rock Biotech Comprehensive Genomic Profiling Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Burning Rock Biotech Comprehensive Genomic Profiling Product Portfolio
- 6.12.5 Burning Rock Biotech Recent Developments
- 6.13 Genetron Health
- 6.13.1 Genetron Health Company Information
- 6.13.2 Genetron Health Business Overview
- 6.13.3 Genetron Health Comprehensive Genomic Profiling Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Genetron Health Comprehensive Genomic Profiling Product Portfolio
- 6.13.5 Genetron Health Recent Developments
- 6.14 Geneseeq
- 6.14.1 Geneseeq Company Information
- 6.14.2 Geneseeq Business Overview
- 6.14.3 Geneseeq Comprehensive Genomic Profiling Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 Geneseeq Comprehensive Genomic Profiling Product Portfolio
- 6.14.5 Geneseeq Recent Developments
- 6.15 BGI Genomics
- 6.15.1 BGI Genomics Company Information
- 6.15.2 BGI Genomics Business Overview
- 6.15.3 BGI Genomics Comprehensive Genomic Profiling Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 BGI Genomics Comprehensive Genomic Profiling Product Portfolio
- 6.15.5 BGI Genomics Recent Developments
- 6.16 Amoy Diagnostics
- 6.16.1 Amoy Diagnostics Company Information
- 6.16.2 Amoy Diagnostics Business Overview
- 6.16.3 Amoy Diagnostics Comprehensive Genomic Profiling Revenue, Global Share and Gross Margin (2021-2026)
- 6.16.4 Amoy Diagnostics Comprehensive Genomic Profiling Product Portfolio
- 6.16.5 Amoy Diagnostics Recent Developments
- 6.17 Roche
- 6.17.1 Roche Company Information
- 6.17.2 Roche Business Overview
- 6.17.3 Roche Comprehensive Genomic Profiling Revenue, Global Share and Gross Margin (2021-2026)
- 6.17.4 Roche Comprehensive Genomic Profiling Product Portfolio
- 6.17.5 Roche Recent Developments
- 6.18 Guardant Health
- 6.18.1 Guardant Health Company Information
- 6.18.2 Guardant Health Business Overview
- 6.18.3 Guardant Health Comprehensive Genomic Profiling Revenue, Global Share and Gross Margin (2021-2026)
- 6.18.4 Guardant Health Comprehensive Genomic Profiling Product Portfolio
- 6.18.5 Guardant Health Recent Developments
- 6.19 Caris Life Sciences
- 6.19.1 Caris Life Sciences Company Information
- 6.19.2 Caris Life Sciences Business Overview
- 6.19.3 Caris Life Sciences Comprehensive Genomic Profiling Revenue, Global Share and Gross Margin (2021-2026)
- 6.19.4 Caris Life Sciences Comprehensive Genomic Profiling Product Portfolio
- 6.19.5 Caris Life Sciences Recent Developments
7 North America
- 7.1 North America Comprehensive Genomic Profiling Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Comprehensive Genomic Profiling Market Size by Country (2021-2026)
- 7.3 North America Comprehensive Genomic Profiling Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Comprehensive Genomic Profiling Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Comprehensive Genomic Profiling Market Size by Country (2021-2026)
- 8.3 Europe Comprehensive Genomic Profiling Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Comprehensive Genomic Profiling Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Comprehensive Genomic Profiling Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Comprehensive Genomic Profiling Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Comprehensive Genomic Profiling Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Comprehensive Genomic Profiling Market Size by Country (2021-2026)
- 10.3 South America Comprehensive Genomic Profiling Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Comprehensive Genomic Profiling Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Comprehensive Genomic Profiling Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Comprehensive Genomic Profiling Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst